chore: daily update 2026-07-28
This commit is contained in:
@@ -11,6 +11,13 @@ Concrete work tasks, follow-ups, approvals, and scheduled items extracted from G
|
||||
- Status: open
|
||||
- Notes: Single credible regulatory-trade source. Pull the NMPA/CDE-direct release before the next vendor sync; check whether any active CellShot-TriArm or ClinoReactor-class deals depend on the new classification scope.
|
||||
|
||||
### celvivo-clinoreactor-thewell-bioscience-xeno-free: verify TheWell Bioscience co-marketing signal on next CelVivo check
|
||||
- Owner: me
|
||||
- Source: web-search — thewellbio.com 2026-07-21 / 2026-07-23 / 2026-07-25 (Xeno-Free Cell Culture Media, Stem Cell Culture Product Guide, Apical-Out Organoids white paper — all explicitly name "CelVivo ClinoReactor™")
|
||||
- Due: unscheduled
|
||||
- Status: open
|
||||
- Notes: First vendor-anchored CelVivo ClinoReactor signal in any Tavily pull (prior pulls returned only MO:BOT / generic organoid). TheWell Bioscience is a hydrogel-media partner; their workflow pages position ClinoReactor as the scale-up vessel for apical-out organoids + hMSC expansion. Confirm with CelVivo whether this is a sanctioned co-marketing arrangement and whether it maps to any active Chinese pharma / CDMO deal.
|
||||
|
||||
<!--
|
||||
Structure for new entries:
|
||||
|
||||
|
||||
Reference in New Issue
Block a user